Literature DB >> 19643941

Rapid reduction in hospitalisations after an intervention to manage severe asthma.

C Souza-Machado1, A Souza-Machado, R Franco, E V Ponte, M L Barreto, L C Rodrigues, J Bousquet, A A Cruz.   

Abstract

Asthma is the third cause of hospitalisations due to clinical illnesses in Brazil. The Programme for Control of Asthma in Bahia (ProAR) leads an initiative in Salvador City (Brazil) to manage severe asthma for free. The aim of this study was to identify trends in asthma hospitalisation in the entire city and to evaluate the impact of ProAR. Information on asthma hospitalisations from 1998 to 2006 was collected. We analysed trends in Salvador (2.8 million inhabitants) before and after ProAR, taking pneumonia and myocardial infarction into account for local comparison. As an external control we obtained information on asthma from Recife, which is the most comparable Brazilian city. In Salvador, asthma hospital admissions declined by 82.3% (1998-2006). A greater proportion of this reduction (74%) occurred after 2003, in parallel with the implementation of ProAR. The reduction in asthma admissions in Recife was smaller. The rates of hospitalisation in 2006 were 2.25 per 10,000 inhabitants in Salvador and 17.06 in Recife. In Salvador, we found an inverse correlation between the provision of medication for asthma and hospitalisation (-0.801; p<0.0001). A rapid reduction in asthma admissions in the entire city of Salvador was associated with ProAR, a public health intervention targeting severe asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643941     DOI: 10.1183/09031936.00101009

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Global Alliance against Chronic Respiratory Diseases (GARD) Brazil success case: overcoming barriers.

Authors:  Alvaro A Cruz; Paulo A Camargos; Marilyn Urrutia-Pereira; Rafael Stelmach
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 2.  Particularities of allergy in the Tropics.

Authors:  Luis Caraballo; Josefina Zakzuk; Bee Wah Lee; Nathalie Acevedo; Jian Yi Soh; Mario Sánchez-Borges; Elham Hossny; Elizabeth García; Nelson Rosario; Ignacio Ansotegui; Leonardo Puerta; Jorge Sánchez; Victoria Cardona
Journal:  World Allergy Organ J       Date:  2016-06-27       Impact factor: 4.084

3.  Asthma care in resource-poor settings.

Authors:  Mario Sánchez-Borges; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  World Allergy Organ J       Date:  2011-04       Impact factor: 4.084

Review 4.  Integrating primary care of chronic respiratory disease, cardiovascular disease and diabetes in Brazil: Practical Approach to Care Kit (PACK Brazil): study protocol for randomised controlled trials.

Authors:  Max O Bachmann; Eric D Bateman; Rafael Stelmach; Álvaro A Cruz; Matheus Pacheco de Andrade; Ronaldo Zonta; Jorge Zepeda; Sonia Natal; Ruth Cornick; Camilla Wattrus; Lauren Anderson; Carl Lombard; Lara R Fairall
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Pattern of asthma medication use among children from a large urban center in Brazil.

Authors:  Djanilson Barbosa Santos; Alvaro A Cruz; Silvia de Magalhães Simões; Laura C Rodrigues; Paulo Augusto Moreira Camargos; Helena Lutescia Luna Coelho; Mauricio L Barreto
Journal:  Eur J Clin Pharmacol       Date:  2011-06-30       Impact factor: 2.953

6.  The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial.

Authors:  Margaret Nampijja; Emily L Webb; James Kaweesa; Robert Kizindo; Milly Namutebi; Esther Nakazibwe; Gloria Oduru; Prossy Kabuubi; Joyce Kabagenyi; Dennison Kizito; Lawrence Muhangi; Mirriam Akello; Jaco J Verweij; Barbara Nerima; Edridah Tukahebwa; Alison M Elliott
Journal:  Trials       Date:  2015-04-23       Impact factor: 2.279

Review 7.  Implementing supported self-management for asthma: a systematic review and suggested hierarchy of evidence of implementation studies.

Authors:  Hilary Pinnock; Eleni Epiphaniou; Gemma Pearce; Hannah Parke; Trish Greenhalgh; Aziz Sheikh; Chris J Griffiths; Stephanie J C Taylor
Journal:  BMC Med       Date:  2015-06-01       Impact factor: 8.775

8.  Montelukast for the high impact of asthma exacerbations in Venezuela: a practical and valid approach for Latin America?

Authors:  Arnaldo Capriles Hulett; Maria Gonzalez Yibirin; Amaris Garcia; Dollys Hurtado
Journal:  World Allergy Organ J       Date:  2014-09-04       Impact factor: 4.084

9.  The impact of a program for control of asthma in a low-income setting.

Authors:  Alvaro A Cruz; Adelmir Souza-Machado; Rosana Franco; Carolina Souza-Machado; Eduardo V Ponte; Pablo Moura Santos; Maurício L Barreto
Journal:  World Allergy Organ J       Date:  2010-04-23       Impact factor: 4.084

10.  Risk factors for death in patients with severe asthma.

Authors:  Andréia Guedes Oliva Fernandes; Carolina Souza-Machado; Renata Conceição Pereira Coelho; Priscila Abreu Franco; Renata Miranda Esquivel; Adelmir Souza-Machado; Alvaro Augusto Cruz
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.